Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haruko Numajiri

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Anticancer Research|November 4, 2021
Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung DiseaseTakashi Saito, Kayoko Ohnishi, Hitoshi Ishikawa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancerYuichi Hiroshima, Nobuyoshi Fukumitsu, Takashi Saito, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2025
Comprehensive analysis of data from a nationwide Japanese cohort on particle therapy for metastatic liver tumorsNobuyoshi Fukumitsu, Shintaro Shiba, Kei Shibuya, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 24, 2014
Dose distribution resulting from changes in aeration of nasal cavity or paranasal sinus cancer in the proton therapyNobuyoshi Fukumitsu, Hitoshi Ishikawa, Kayoko Ohnishi, et al.
Liver Cancer|January 21, 2026
Proton Beam Therapy for Untreated Hepatocellular Carcinoma Unsuitable for Transcatheter Arterial ChemoembolizationHikaru Niitsu, Hirokazu Makishima, Naoyuki Hasegawa, et al.
Journal of Medical Radiation Sciences|October 19, 2021
Acute toxicity and patient-reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancerTakashi Iizumi, Hitoshi Ishikawa, Yuta Sekino, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2014
Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapyMasashi Mizumoto, Yoshiko Oshiro, Toshiyuki Okumura, et al.
Japanese Journal of Radiology|April 17, 2015
Prediction error and required internal margin provided for irregular respiratory movements: a phantom studyNobuyoshi Fukumitsu, Haruko Numajiri, Kayoko Ohnishi, et al.
International Journal of Particle Therapy|January 15, 2026
Japanese Nationwide Prospective Data of Proton Therapy for Liver Metastasis From Pancreatic CancerHisashi Yamaguchi, Nobuyoshi Fukumitsu, Haruko Numajiri, et al.
Japanese Journal of Radiology|May 12, 2018
Simulation study of dosimetric effect in proton beam therapy using concomitant boost technique for unresectable pancreatic cancersNobuyoshi Fukumitsu, Toshiyuki Okumura, Yuichi Hiroshima, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Anticancer Research|November 4, 2021
Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung DiseaseTakashi Saito, Kayoko Ohnishi, Hitoshi Ishikawa, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 25, 2019
Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancerYuichi Hiroshima, Nobuyoshi Fukumitsu, Takashi Saito, et al.
International Journal of Radiation Oncology, Biology, Physics|July 28, 2025
Comprehensive analysis of data from a nationwide Japanese cohort on particle therapy for metastatic liver tumorsNobuyoshi Fukumitsu, Shintaro Shiba, Kei Shibuya, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 24, 2014
Dose distribution resulting from changes in aeration of nasal cavity or paranasal sinus cancer in the proton therapyNobuyoshi Fukumitsu, Hitoshi Ishikawa, Kayoko Ohnishi, et al.
Liver Cancer|January 21, 2026
Proton Beam Therapy for Untreated Hepatocellular Carcinoma Unsuitable for Transcatheter Arterial ChemoembolizationHikaru Niitsu, Hirokazu Makishima, Naoyuki Hasegawa, et al.
Journal of Medical Radiation Sciences|October 19, 2021
Acute toxicity and patient-reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancerTakashi Iizumi, Hitoshi Ishikawa, Yuta Sekino, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2014
Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapyMasashi Mizumoto, Yoshiko Oshiro, Toshiyuki Okumura, et al.
Japanese Journal of Radiology|April 17, 2015
Prediction error and required internal margin provided for irregular respiratory movements: a phantom studyNobuyoshi Fukumitsu, Haruko Numajiri, Kayoko Ohnishi, et al.
International Journal of Particle Therapy|January 15, 2026
Japanese Nationwide Prospective Data of Proton Therapy for Liver Metastasis From Pancreatic CancerHisashi Yamaguchi, Nobuyoshi Fukumitsu, Haruko Numajiri, et al.
Japanese Journal of Radiology|May 12, 2018
Simulation study of dosimetric effect in proton beam therapy using concomitant boost technique for unresectable pancreatic cancersNobuyoshi Fukumitsu, Toshiyuki Okumura, Yuichi Hiroshima, et al.
Pageof 8